These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


338 related items for PubMed ID: 16324745

  • 21. A comparative study on the relationship between various toxicological endpoints in Caenorhabditis elegans exposed to organophosphorus insecticides.
    Rajini PS, Melstrom P, Williams PL.
    J Toxicol Environ Health A; 2008; 71(15):1043-50. PubMed ID: 18569613
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Combined atropine and 2-PAM Cl effects on tracking performance and visual, physiological, and psychological functions.
    Penetar DM, Haegerstrom-Portnoy G, Jones RT.
    Aviat Space Environ Med; 1988 Dec; 59(12):1125-32. PubMed ID: 3240212
    [Abstract] [Full Text] [Related]

  • 24. Protective effects of S+ ketamine and atropine against lethality and brain damage during soman-induced status epilepticus in guinea-pigs.
    Dorandeu F, Baille V, Mikler J, Testylier G, Lallement G, Sawyer T, Carpentier P.
    Toxicology; 2007 May 20; 234(3):185-93. PubMed ID: 17408839
    [Abstract] [Full Text] [Related]

  • 25. New treatment regimens in organophosphate (diazinon) and carbamate (methomyl) insecticide-induced toxicosis in fowl.
    Shlosberg A, Bellaiche M, Hanji V, Ershov E.
    Vet Hum Toxicol; 1997 Dec 20; 39(6):347-50. PubMed ID: 9397503
    [Abstract] [Full Text] [Related]

  • 26. Phosphotriesterase, pralidoxime-2-chloride (2-PAM) and eptastigmine treatments and their combinations in DFP intoxication.
    Tuovinen K, Kaliste-Korhonen E, Raushel FM, Hänninen O.
    Toxicol Appl Pharmacol; 1996 Dec 20; 141(2):555-60. PubMed ID: 8975781
    [Abstract] [Full Text] [Related]

  • 27. The role of cholinergic and noncholinergic mechanisms in the cardiorespiratory failure produced by N-methylcarbamate cholinesterase inhibitors in rabbits.
    Futagawa H, Kakinuma Y, Takahashi H.
    Toxicol Appl Pharmacol; 2000 May 15; 165(1):27-36. PubMed ID: 10814550
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effect of intrathecal pralidoxime administration upon survival of rats exposed to the organophosphate paraoxon.
    Lorke DE, Hasan MY, Nurulain SM, Shafiullah M, Nagelkerke N, Petroianu GA.
    Neurotoxicology; 2008 Jul 15; 29(4):663-70. PubMed ID: 18457881
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Pralidoxime rescues both muscarinic and nicotinic systems.
    Petroianu GA.
    Anesth Analg; 2005 Sep 15; 101(3):926-927. PubMed ID: 16116023
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Organo-phosphate induced delayed neuropathy: report of two cases.
    Singh S, Ranjit A, Parthasarathy S, Sharma N, Bambery P.
    Neurol India; 2004 Dec 15; 52(4):525-6. PubMed ID: 15626866
    [No Abstract] [Full Text] [Related]

  • 37. Combined Pre- and Posttreatment of Paraoxon Exposure.
    Lorke DE, Nurulain SM, Hasan MY, Kuča K, Petroianu GA.
    Molecules; 2020 Mar 27; 25(7):. PubMed ID: 32230733
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 17.